| Anthony P Munaco, MD | |
|
36175 Harper Ave, Clinton Township, MI 48035-3274 | |
| (586) 741-3772 | |
| (586) 741-4604 |
| Full Name | Anthony P Munaco |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 37 Years |
| Location | 36175 Harper Ave, Clinton Township, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134108368 | NPI | - | NPPES |
| 1006439 | Other | MI | MCLAREN HEALTH |
| 106191 | Other | MI | GREAT LAKES HEALTH |
| 2882911 | Medicaid | MI | |
| 0H26188 | Other | MI | BCBS PROVIDER NUMBER |
| 0Q26008 | Other | MI | BCBS PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301051178 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St John Hospital | Detroit, MI | Hospital |
| Henry Ford Macomb Hospital | Clinton township, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastpointe Radiologists Pc | 7618876327 | 61 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is initiating a multi-center clinical trial of its Symphony CGM System to support a CE Mark Technical File for marketing approval in Europe.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Moores Cancer Center at the University of California San Diego (UCSD) has filed an Investigational New Drug Application with the U.S. Food & Drug Administration ("FDA") for approval to test Nupen, Apricus Bio's proprietary, topical NexACT-based formulation of filgrastim (Neupogen).
Kaiser Health News: Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country"
Lung cancer is the leading cause of preventable cancer death. A disease of complex origin, lung cancer is usually considered to result from effects of smoking and from multiple genetic variants.
› Verified 1 days ago
| Entity Name | Eastpointe Radiologists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558409649 PECOS PAC ID: 7618876327 Enrollment ID: O20031231000704 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is initiating a multi-center clinical trial of its Symphony CGM System to support a CE Mark Technical File for marketing approval in Europe.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Moores Cancer Center at the University of California San Diego (UCSD) has filed an Investigational New Drug Application with the U.S. Food & Drug Administration ("FDA") for approval to test Nupen, Apricus Bio's proprietary, topical NexACT-based formulation of filgrastim (Neupogen).
Kaiser Health News: Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country"
Lung cancer is the leading cause of preventable cancer death. A disease of complex origin, lung cancer is usually considered to result from effects of smoking and from multiple genetic variants.
› Verified 1 days ago
| Entity Name | Henry Ford Macomb Ancillary Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669864708 PECOS PAC ID: 6305164500 Enrollment ID: O20150420001928 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is initiating a multi-center clinical trial of its Symphony CGM System to support a CE Mark Technical File for marketing approval in Europe.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Moores Cancer Center at the University of California San Diego (UCSD) has filed an Investigational New Drug Application with the U.S. Food & Drug Administration ("FDA") for approval to test Nupen, Apricus Bio's proprietary, topical NexACT-based formulation of filgrastim (Neupogen).
Kaiser Health News: Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country"
Lung cancer is the leading cause of preventable cancer death. A disease of complex origin, lung cancer is usually considered to result from effects of smoking and from multiple genetic variants.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony P Munaco, MD 36175 Harper Ave, Clinton Township, MI 48035-3274 Ph: (586) 741-3772 | Anthony P Munaco, MD 36175 Harper Ave, Clinton Township, MI 48035-3274 Ph: (586) 741-3772 |
News Archive
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is initiating a multi-center clinical trial of its Symphony CGM System to support a CE Mark Technical File for marketing approval in Europe.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing partnerships, today announced that the Moores Cancer Center at the University of California San Diego (UCSD) has filed an Investigational New Drug Application with the U.S. Food & Drug Administration ("FDA") for approval to test Nupen, Apricus Bio's proprietary, topical NexACT-based formulation of filgrastim (Neupogen).
Kaiser Health News: Less than 24 hours after Republicans won control of the House, soon-to-be-speaker John Boehner denounced the new health care law, saying it would "kill jobs in America, ruin the best health care system in the world, and bankrupt our country"
Lung cancer is the leading cause of preventable cancer death. A disease of complex origin, lung cancer is usually considered to result from effects of smoking and from multiple genetic variants.
› Verified 1 days ago
Dr. Onowenerhi Benedictta Omene, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 36175 Harper Ave, Clinton Township, MI 48035 Phone: 586-464-0731 Fax: 586-464-1954 | |
Kyoung Soo Bae, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 36175 Harper Ave, Clinton Township, MI 48035 Phone: 586-741-3772 Fax: 586-741-4604 | |
Michael P. Trpkovski, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 36175 Harper Ave, Clinton Township, MI 48035 Phone: 586-464-0740 | |
Cadie Lee Cunningham, Radiology Medicare: Not Enrolled in Medicare Practice Location: 38654 Bay Ln, Clinton Township, MI 48038 Phone: 586-854-2533 | |
Rojanandham Samudrala, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 36175 Harper Ave, Clinton Township, MI 48035 Phone: 586-741-3772 Fax: 586-741-4604 | |
Mrs. Cynthia Marie Wheeler, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 36175 Harper Ave, Clinton Township, MI 48035 Phone: 586-741-3772 Fax: 586-741-4604 |